| 000 | 01836 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517172915.0 | ||
| 264 | 0 | _c20180103 | |
| 008 | 201801s 0 0 eng d | ||
| 022 | _a1473-5741 | ||
| 024 | 7 |
_a10.1097/CAD.0000000000000561 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJin, Junfei | |
| 245 | 0 | 0 |
_aBcl-2 and Bcl-xL mediate resistance to receptor tyrosine kinase-targeted therapy in lung and gastric cancer. _h[electronic resource] |
| 260 |
_bAnti-cancer drugs _c11 2017 |
||
| 300 |
_a1141-1149 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAniline Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Nude |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRandom Allocation |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aUp-Regulation |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 650 | 0 | 4 |
_abcl-X Protein _xantagonists & inhibitors |
| 700 | 1 | _aXiong, Ying | |
| 700 | 1 | _aCen, Bo | |
| 773 | 0 |
_tAnti-cancer drugs _gvol. 28 _gno. 10 _gp. 1141-1149 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/CAD.0000000000000561 _zAvailable from publisher's website |
| 999 |
_c27540708 _d27540708 |
||